Rebirth: Super Banking System Chapter 2327 - 2167: Surge

Previously on Rebirth: Super Banking System...
Zhou Yan exited the examination area to preserve dignity during the live broadcast, as viewers anticipated swift results. The announcement of an Alzheimer's cure sparked widespread excitement online, with netizens sharing stories of affected families and driving live stream viewership to a platform record. In the consultation, the doctor explained to the elderly patient and his relative that early-stage treatment required one month of injections every three days, costing about thirty thousand Asia Dollars for a decade without relapse, extendable lifelong with minimal follow-up. Relieved by the affordable pricing and visa extensions for medical stays, they obtained initial oral medications, viewing the approach as exceptionally conscientious.

Once the medication was obtained.

Right at the entrance.

"Thank you!" The lady expressed her gratitude to the nurse. This turned out to be the most uplifting update she'd received in ages, just like a burst of warm rays piercing through a chilly winter day.

Her very breaths seemed renewed.

"Be careful out there."

The nurse offered a warm grin.

Time for discharge.

As they strolled along.

The lady shared the doctor's remarks with Zhou Yan and the over 800,000 watchers in the livestream, where the viewer count had skyrocketed. Upon hearing it, the comment section lit up like fireworks.

"Under thirty thousand for the initial phase? That's surprisingly affordable."

"So thoughtful!"

"Absolutely, once it advances to the middle phase, yearly upkeep expenses skyrocket far beyond that. It could transform countless households—a truly noble charitable effort."

"Exactly, exactly!"

"Similar to cancer costs, yet without insurance coverage. For struggling families, this sum hits hard. Urgent push to add it to medical insurance."

"Totally agree."

"I'm in favor."

"..."

A wave of thrilled reactions poured in. From three to fifty thousand, it might seem steep, and insurance doesn't cover it yet, but weighed against the disease's worsening.

It's incredibly compassionate.

Losing the ability to talk.

Forgetting everything.

Becoming paralyzed.

...

Just the caregiving expenses could multiply tenfold. Loads of folks hurriedly visited the Myanmar Pharmaceutical Group's official site.

Eager to book slots.

After all.

With the medicine freshly launched, it won't reach other nations anytime soon. So, for care, most need to head to Yangon promptly and secure appointments fast.

Doubting its effectiveness?

Ha!

Impossible!

Would Myanmar Pharmaceutical Group chase cash like that? No chance they'd peddle fakes.

But.

Logging in revealed that Alzheimer’s wasn't listed for bookings yet. Trying to reserve under cancer and negotiate later? Not an option.

At present.

Cancer bookings demand verification.

If not.

Grabbing a slot just for a joyride to the place, blocking spots for those in dire need, would irritate everyone. Incidents like that have occurred.

And frequently.

That's why.

It turned into a strict policy.

Anxiety building.

Itching to contact support.

All of a sudden.

A notification appeared on the site: For details on Alzheimer’s treatment, click here. Spotting this, viewers couldn't help but praise the site's quick response.

No surprise.

Zhou Yan's unexpected livestream today caught them off guard, yet in under twenty minutes, they'd rolled out measures—impressively swift.

"So considerate."

"Let's check it out."

"..."

With that.

They tapped the link.

The page shifted.

A fresh section loaded with all the details. Finishing the read, sighs of relief echoed everywhere. Thankfully, it confirmed the facts, no denial piece.

Only.

Booking guidelines were outlined.

To start.

A confirmed diagnosis is essential to stop casual applications from clogging the queue.

...

Next.

Caregiving matters.

After all.

With this illness, sending a patient solo wouldn't sit well with relatives or the Myanmar Pharmaceutical Group, so a minimum of one attendant must accompany.

...

Finally.

The hottest debate.

Different from cancer.

At first.

Advanced cases got top spots.

But now, early and mid-stages come first. Late-stage patients should opt for local options, essentially getting the drug approved domestically.

The reason?

Curiosity spiked among many. One idea: Myanmar Pharmaceutical Group aims for global listings, making this a smart move.

Another idea.

Dodging complications.

After all.

In late stages.

Victims are often confined to beds, barely moving, speechless, struggling to eat, moods swinging wildly, losing control of bodily functions...

Flying might prove impossible.

By sea.

By road.

Maybe doable, but for remote spots, the grueling journey to Yangon could drag on forever, facing endless stares and hurdles.

Hence.

Folks largely accepted this stipulation without fuss.

The top theory making sense: Yangon's hospitals discourage admissions due to limited beds, and a flood of patients would overwhelm them.

...

In closing.

Treatment pricing details.

Like always, pay after starting care. Rates stay fair and capped, no spiraling costs like the endless drain from before.

Cash tight?

Loans are tough.

Yet.

A fixed limit simplifies things. Kin and pals can chip in to cover it, no fear of it turning into an unending money sink for drugs.

Everyone's ready to pitch in.

A couple thousand.

No sweat.

Tens of thousands.

It's for restoring a life. Thus, expense worries fade away.

...

Soon after.

Booking opened up.

Right away.

Requests poured in like a torrent. Early bookers discovered.

Wow!

Slots available in just a week—beyond thrilled, expecting months-long waits. Quickly, the why clicked: Yangon New City boasts plenty of dedicated housing.

Set aside on purpose.

Going forward.

These cases will mostly stay in Yangon New City.

"This firm deserves endless praise, a million thumbs up."

"Healers with kind souls."

"Amazing!"

"..."

Post-booking.

Bursting with joy, they shared the update with loved ones, and upon hearing, relatives beamed with delight, hurrying to offices for passports and tickets.

Far-off spots meant no alternatives, flights packed, so multiple connections; close ones, like nearby nations, stuck to overland routes.

For a moment.

Buzz filled the air.

...

In Beijing.

Some research facility.

"Director Shi, fantastic news!" A scientist burst into Shi Ze's office, face alight with enthusiasm as he announced it. Shi Ze, buried in desk work, glanced up.

Brow furrowing, he queried:

"What's up?"

"Your ailment can be cured."

"What?"

Shi Ze froze in surprise, then after the rundown.

"Is that true?"

He leaped to his feet, thrilled.

Elated.

For all the sufferers out there,

And for his own sake too.

Before.

He'd joined a team trip to Myanmar probing the Transcription Fluid, only to learn he was a year shy of early Alzheimer’s signs, leaving him on edge.

Who'd have thought.

Soon, word came of a breakthrough.

They had a cure.

Now.

Two years of waiting.

Last year.

Early signs confirmed.

Endured the wait!

Clung to hope!

At last.

The remedy arrived today. On its power, zero skepticism—last visit's cutting-edge tech had blown minds.

If Transcription Fluid was a fluke of science.

Pure fortune.

Then.

-Diagnostic pods.

-Surgery suites.

-Novel therapies.

Defy chance alone, showcasing elite mechanical prowess, maybe surpassing Huaxia's.

Else.

Countless components and designs remain beyond Huaxia's grasp.

Simply.

No fresh innovations have stolen the spotlight like that since, dimming this feat. He even joked in his mind: Could it be extraterrestrial tech?

Alright,

Mere fancy—the world isn't so unforgiving.

Why?

Extraterrestrials.

Should they be real and snagged by Ling's crew, imagine the devastating secrets they'd hold? Too wild to fathom, rendering this reality almost merciful. So, what's truly harsh?

Table of content
Loading...